Insider trading · Q3 2026 · CIK 1773751

Hims & Hers Health, Inc. (HIMS) insider trading.

In Q3 2026, insiders at Hims & Hers Health, Inc. reported 40 non-derivative transactions on 33 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $6.1M.

Transactions
40
Purchases (P)
0
Sales (S)
13
Net shares, P minus S
-199,184
Insiders
11
Last filed
2026-09-23

Insiders

InsiderRelationshipTransactionsBuysSales
Okupe OluyemiOfficer · Chief Financial Officer1407
Boughton SoleilOfficer · Chief Legal Officer503
Dudum AndrewDirector, Officer, TenPercentOwner · Chief Executive Officer400
Chi MichaelOfficer · Chief Operating Officer301
Elshenawy MohamedOfficer · CTO301
Autor Deborah M.Director, Officer · Chief Policy Officer301
Carroll Patrick HarrisonOfficer · Chief Medical Officer300
Becklund IreneOfficer · PAO200
Payne Christopher DDirector100
Wells David BDirector100
Schultz KareDirector100

Transactions

40 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-22Okupe OluyemiM (A)14,000$5.01265,804Form 4
2026-09-22Okupe OluyemiS (D)29,277$29.95236,527Form 4
2026-09-17Okupe OluyemiS (D)12,313$28.82251,804Form 4
2026-09-16Boughton SoleilS (D)6,236$27.86304,270Form 4
2026-09-15Chi MichaelS (D)14,027$28.39456,660Form 4
2026-09-15Elshenawy MohamedS (D)7,954$28.39185,556Form 4
2026-09-02Boughton SoleilS (D)3,458$28.33310,506Form 4
2026-08-27Dudum AndrewJ (D)977,566$0103,406Form 4
2026-08-25Dudum AndrewG (D)463,289$00Form 4
2026-08-19Boughton SoleilS (D)25,111$27.55313,964Form 4
2026-08-19Okupe OluyemiM (A)4,938$5.01269,055Form 4
2026-08-19Okupe OluyemiS (D)4,938$29.99264,117Form 4
2026-08-18Autor Deborah M.S (D)16,773$27.8548,961Form 4
2026-08-17Okupe OluyemiM (A)9,388$5.01273,505Form 4
2026-08-17Okupe OluyemiS (D)9,388$27.89264,117Form 4
2026-08-14Payne Christopher DM (A)545—34,863Form 4
2026-08-14Becklund IreneF (D)6,490$28.1513,985Form 4
2026-08-14Becklund IreneM (A)13,685—20,475Form 4
2026-08-14Elshenawy MohamedF (D)95,798$28.15193,510Form 4
2026-08-14Elshenawy MohamedM (A)188,285—289,308Form 4
2026-08-14Wells David BM (A)778—229,808Form 4
2026-08-14Autor Deborah M.M (A)32,920—81,881Form 4
2026-08-14Autor Deborah M.F (D)16,147$28.1565,734Form 4
2026-08-14Okupe OluyemiF (D)36,437$28.15264,117Form 4
2026-08-14Okupe OluyemiM (A)71,616—300,554Form 4
2026-08-14Chi MichaelM (A)86,265—518,389Form 4
2026-08-14Chi MichaelF (D)47,702$28.15470,687Form 4
2026-08-14Dudum AndrewM (A)154,993—1,112,036Form 4
2026-08-14Dudum AndrewF (D)78,859$28.151,033,177Form 4
2026-08-14Carroll Patrick HarrisonM (A)260—182,121Form 4
2026-08-14Carroll Patrick HarrisonM (A)25,927—208,048Form 4
2026-08-14Carroll Patrick HarrisonF (D)10,201$28.15197,847Form 4
2026-08-14Schultz KareM (A)6,623—26,020Form 4
2026-08-14Boughton SoleilF (D)21,500$28.15339,075Form 4
2026-08-14Boughton SoleilM (A)42,261—360,575Form 4
2026-07-17Okupe OluyemiS (D)7,163$31.99284,321Form 4
2026-07-17Okupe OluyemiM (A)7,163$5.01291,484Form 4
2026-07-06Okupe OluyemiM (A)7,163$5.01291,484Form 4
2026-07-06Okupe OluyemiS (D)7,163$36.49284,321Form 4
2026-06-18Okupe OluyemiS (D)55,383$35.09228,938Form 4

Transaction codes in this quarter

Get HIMS insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1773751&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · HIMS company page · Hims & Hers Health, Inc. on SEC.gov

Questions

Are insiders buying or selling Hims & Hers Health, Inc. (HIMS)?

In Q3 2026, insiders at Hims & Hers Health, Inc. reported 40 non-derivative transactions on 33 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $6.1M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Hims & Hers Health, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/hims.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.